Urologic Oncology Fellowship

Urologic Oncology Fellowship

The Urologic Oncology Fellowship at Vanderbilt prepares and trains academic leaders in the field at a high-volume regional and national referral center for comprehensive genitourinary cancer care.

Fellows work with our nationally and internationally recognized faculty, which includes nine fellowship-trained urologic oncologists.  The program emphasizes multidisciplinary oncologic diagnosis, evaluation, treatment, and surveillance for all urologic cancer types.

The Vanderbilt Urologic Oncology Fellowship is accredited by the Society of Urologic Oncology (SUO).  Fellows who complete our two-year Urologic Oncology Fellowship, can demonstrate:

  • Advanced expertise in multidisciplinary management of patients with urologic cancer 
  • Knowledge and ability in applying critical principles of medical oncology, radiation oncology, uropathology and imaging techniques 

Outstanding Faculty

The clinical urologic oncology faculty includes:

Our faculty shares with fellows its broad-ranging backgrounds, interests, and extensive clinical training and expertise, as well as accomplishments in research, medical policy, and representation in journals.

Advanced techniques. Our faculty use, study and advance the most current surgical techniques, including:

  • Laparoscopy 
  • Robotic-assisted laparoscopy 
  • Ablative and thermal techniques 
  • Image guided therapies 

Research. Each faculty member actively engages in clinical and/or translational research as evidenced by the impact of Vanderbilt publications and grants awarded to our faculty. Three Department of Urology research laboratories run by independently funded PhD scientists, produce consistent excellence in grant funding, research publication and training of fellows.
Leadership. Vanderbilt urologic oncology faculty are leaders in the field and are involved at the highest level of organizational urology through national and international committees, such as:

  • Leading American Urological Association (AUA) clinical guidelines on  
    • Advanced Prostate Cancer 
    • Bladder Cancer 
    • Small Renal Masses 
    • Follow-up of Renal Masses 
    • Hematuria evaluation 
  • Leading National Comprehensive Cancer Center (NCCN) guidelines on 
    • Prostate cancer  
    • Bladder cancer  
    • Kidney cancer 
    • Testis cancer 
  • Chairing the American Joint Committee on Cancer’s Genitourinary staging committee
  • Vanderbilt urologic oncology faculty lead (or have led) the:
    • SUO Executive Committee 
    • AUA Health Policy Board  
    • AUA Public Media Committee 
    • SUO Young Urologic Oncologists executive committee 
    • OKAT (Oncology Knowledge Assessment Test) committees
    • American Board of Urology Examination Committee   

Publishing. Our faculty is committed to education and serves as chair or as members of the editorial staffs of several journals, including:

  • Journal of Urology 
  • Urology 
  • Urologic Oncology 
  • Urology Practice 

Program Overview

Our Urologic Oncology Fellowship provides comprehensive training in the evaluation and management of urologic malignancies, as well as the tools to evaluate and contribute to the research in this field. Fellows complete a clinical year followed by a research year.

Fellows acquire advanced expertise in the multidisciplinary management of urologic cancers, including the ability to apply the critical principles of: 

  • Radiation oncology 
  • Medical oncology 
  • Urologic imaging  
  • Pathology 
  • Advanced understanding of the biology of urologic malignancies through: 
  • Clinical experiences 
  • Self-directed learning 

The Urologic Oncology curriculum 

  • Research endeavors, including learning: 
    • Study design 
    • Biostatistics 
    • Clinical trials 
    • Data analysis 
    • Scientific methodology 
    • Laboratory research 

We adhere to the same goals as the SUO accrediting body, including teaching our fellows:

  • To manage a clinical practice 
  • To participate in continuing education 
  • Skills for self-education 
  • To collaborate in translational research 

Conferences and Workshops

At Vanderbilt, fellows participate in multiple conferences and attend association and professional workshops and meetings.

Conference schedule:

  • Radiographic Case Discussion 
  • Department meeting 
  • Journal Club 
  • Research meeting
  • Multidisciplinary Tumor Board (Wednesdays) 
  • Bi-Monthly Oncology Conference 
  • Research Updates
  • Didactic conference (Fridays) 
  • Pathology conference

These conferences provide a framework for learning the biology of urologic cancers and a stimulus for research investigation.

  • American Association for Cancer Research Molecular Biology in Clinical Oncology Workshop 
  • Biostatistics (MPH course) 
  • Society of Urologic Oncology 
  • Southeastern Section of the American Urological Association (SESAUA) 
  • AUA meetings 
  • Genitourinary Cancers Symposium-American Society of Clinical Oncology (ASCO) 
  • ASCO meetings 

Clinical Program

First-year fellows dedicate their time to clinical training and the development of surgical skills and clinical acumen. Fellows spend three days a week in a surgical setting and one and a half days each week in the clinic, learning the intricacies of the multidisciplinary management of urologic cancers.

Intensive surgical training includes hands-on experience in:

  • Open surgery 
  • Laparoscopy 
  • Robotic surgery  
  • Energy-ablative and image-guided techniques

The team approach has always been emphasized at Vanderbilt.  As a result, there is extensive and close interaction with residents, medical students, and co-fellows.  Shared learning as well as independent experiences are promoted and supported.
After Jan. 1 of the first fellowship year, fellows earn:

  • Faculty appointment 
  • Opportunity to book, identify your own cases and have your own clinic time (once/month) 
  • Moonlighting opportunities

Research Program

Second and third-year fellows spend their time on research. Fellows start a research project or projects under the guidance of one or more research mentors. Some fellows begin their research projects before arriving at Vanderbilt. The goals are to:

  • Acquire research skills that can be applied to a career in academic Urologic Oncology 
  • Make impactful contributions to the care of patients with urologic cancers 

Our fellows enjoy independence and latitude in their research, which yields many:

  • Significant gains and understanding around many clinical questions  
  • Numerous publications 

Research laboratories. Many fellows work in one of our department’s research laboratories. One possible faculty mentor is Robert Matusik, PhD. Dr. Matusik’s research focuses on androgen regulation of gene expression, and his lab develops novel transgenic mouse models for prostate cancer.
Health services research. Some fellows pursue health services research, working within the Center for Surgical Quality and Outcomes Research. Faculty member David Penson, MD, MPH. Dr. Penson is Principal Investigator of the Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) study on prostate cancer and was awarded a $7.6 million dollar stimulus grant for the study. Faculty member Daniel Barocas, MD, MPH, is a co-investigator on this study and is another member of the Urology faculty with expertise in health services research.

CJ Stimson MD, JD provides unique opportunities for fellows interested in health care policy, health care delivery and payment transformation, and value-based care. Through policy-oriented research or strategy and operations preceptorships, Dr. Stimson gives Vanderbilt urologic oncology fellows the opportunity to lay the foundation for a career at the intersection of clinical care, health care policy, and health care administration.  

Research opportunities. Our fellows enjoy varied research avenues, including:

Beyond the lab:

  • Masters of Public Health 
  • Masters of Science in Clinical Investigation 
  • Masters of Clinical Informatics 
  • Individualized clinical and translational projects


Fellows work and learn in multiple Vanderbilt facilities, including:

Global Health

Global health missions are available for fellows who are interested. Faculty member Joseph A. Smith, Jr. MD, leads trips to Africa to train doctors there in urologic procedures and to provide care for residents who need it.
Fellows plan and design each trip, look for research opportunities and gain experience in teaching and learning from others. Our Global Health missions expose fellows to:

  • Global surgery 
  • Experience in continually giving back 
  • Creatively innovating to find surgical and care solutions 
  • Working with others from varied backgrounds  


Our Fellowship in Urologic Oncology includes the following requirements:

  • All programs must be at least 24 months in duration. 
  • The clinical portion must be a minimum of 12 months in duration. 
  • The research portion must be a minimum of 12 months in duration. 
  • The trainee may start either in the clinical or research rotation.

Application and Interview Process
If you are interested in our Fellowship in Urologic Oncology, please apply at least 19 months before you complete your residency, or by January 1 of the year preceding the chief residency year.
Before applying for the fellowship, you must have taken or be registered to take the qualifying portion (Part I) of the American Board of Urology (ABU) exam or be board certified by the ABU. Medical Center and Department policies require a U.S. medical license to move forward in the selection process.
You must formally register for the Match on the Society of Urologic Oncology (SUO) website. After you register, you will receive an assigned number via email from the American Urological Association (AUA). This number will be essential when the match results are announced.
Download the Fellowship Match Application PDF from the Society of Urologic Oncology (SUO) website. Complete the application and forward it to us, along with your other materials.
To apply, please send:

  • A copy of your CV 
  • Personal statement 
  • Three letters of reference, including: 
  • A letter of support from your program director  
  • A letter from a faculty member recommending you for the fellowship and attesting to your successful completion of the urology training program 

Mail or email your documents to:
Sam S. Chang, MD, MBA  Fellowship Program Director  Department of Urology
1161 21st Ave. South  A-1302 MCN  Nashville, TN 37232
sam.chang@vumc.org with a copy to michele.clark@vumc.org
For questions, please email Michele Clark at michele.clark@vumc.org.
Interviews.  Our fellowship interviews take place at Vanderbilt on a date to be distributed to those who proceed after initial screening is completed. The Preference List Phase usually begins in May, when applicants and our program submit their Rank and Preference Lists. The SUO provides specific instructions.
Please refer to the SUO website for the Match List Submission Deadline and announcement of Match Results.

Our Fellows

At Vanderbilt, our fellows achieve outstanding clinical and research goals during and after their fellowships. Our fellows go on to lead academic urology and research programs and train future leaders in our field.

Our current and past fellows include:

Christopher Wallis, MD

  • Vanderbilt Urologic Oncology Fellowship - 2019 (will graduate 2021)  
  • Medical School: University of British Columbia (Graduated 2011) 
  • Residency: University of Toronto (Graduates June 30, 2019) 

Current Position:
Vanderbilt University Medical Center
A-1302 Medical Center North
Nashville, TN 37232-2765
Amy Luckenbaugh, MD

  • Vanderbilt Urologic Oncology Fellowship - 2018-Present (will graduate 2020) 
  • Medical School: State University of New York at Buffalo (Graduated 2013) 
  • Residency: University of Michigan (Graduated 2018) 

Current Position:
Vanderbilt University Medical Center
A-1302 Medical Center North
Nashville, TN 37232-2765
Aaron Laviana, MD

  • Vanderbilt Urologic Oncology Fellowship - 2017-Present (will graduate 2020) 
  • Medical School: Georgetown University, School of Medicine (Graduated 2011) 
  • Residency:  University of California, Los Angeles (Graduated 2017) 

Current Position:
Vanderbilt University Medical Center
A-1302 Medical Center North
Nashville, TN 37232-2765
Daniel Lee, MD

  • Vanderbilt Urologic Oncology Fellowship - 2016-2018 
  • Medical School:  SUNY Stony Brook Medical School (Graduated 2010) 
  • Residency:  New York Presbyterian Hospital-Weill Cornell Medical Center (Graduated 2016) 

Current Position
Assistant Professor
Perelman Center for Advanced Medicine, Penn Urology
3rd Floor, West Pavilion
3400 Civic Center Blvd
Mark Tyson, MD

  • Vanderbilt Urologic Oncology Fellowship - 2015-2017 
  • Medical School: Dartmouth Medical School (Graduated 2010) 
  • Residency:  Mayo Clinic, Arizona (Graduated 2015) 

Current Position:
Assistant Professor of Urology
Mayo Clinic Phoenix
July 2017-Present
Mayo Clinic 
5777 E. Mayo Blvd
Phoenix, AZ 85054
Kristen R. Scarpato, MD, MPH

  • Vanderbilt Urologic Oncology Fellowship - 2014-2016 
  • Medical School:  Tufts University, School of Medicine (Graduated 2009) 
  • Residency:  University of Connecticut (Graduated 2014) 

Current Position:
Assistant Professor/Residency Program Director
Vanderbilt University Medical Center
2016 - Present
A-1302 Medical Center North
Nashville, TN 37232
Brock B. O’Neil, MD

  • Vanderbilt Urologic Oncology Fellowship - 2014-2016 
  • Medical School: University of Rochester (Graduated 2009) 
  • Residency:  University of Utah (Graduated 2014) 

Current Position:
Assistant Professor
University of Utah
Huntsman Cancer Hospital
1950 Circle of Hope
Salt Lake City, UT 84112
John Eifler, MD

  • Vanderbilt Urologic Oncology Fellowship - 2013-2015 
  • Medical School: New York Presbyterian Hospital-Weill Cornell Medical Center (Graduated 2007) 
  • Residency: Johns Hopkins (Graduated 2015) 

Current Position:
First Urology
2304 Merrick Road
Louisville, KY 40207
William Sohn, MD

  • Vanderbilt Urologic Oncology Fellowship - 2013-2015 
  • Medical School: New York Medical College (Graduated 2007) 
  • Residency:  University of California, Irvine (Graduated 2013) 

Current Position:
Staff Surgeon
Southern California Permanente Medical Group
9985 Sierra Avenue
Urology, MOB 3, 2nd Floor
Fontana, CA 92335
Jeffrey C. Bassett, MD, MPH

  • Vanderbilt Urologic Oncology Fellowship - 2012-2014 
  • Medical School: University of Pittsburgh School of Medicine (Graduated 2006) 
  • Residency:  David Geffen School of Medicine at UCLA (Graduated 2012) 

Current Position:
Kaiser Permanente
Orange County, CA
3430 E. La Palma Avenue
Anaheim, CA 92806
Chad Ritch, MD, MBA

  • Vanderbilt Urologic Oncology Fellowship - 2012-2014 
  • Medical School: University of Chicago, Pritzker School of Medicine (Graduated 2006) 
  • Residency:  Columbia University Medical Center (Graduated 2012) 

Current Position:
Assistant Professor of Urology
University of Miami
Professional Arts Center
1150 NW 14th St, Suite 309
Miami, FL 33136
Matthew J. Resnick, MD, MPH

  • Vanderbilt Urologic Oncology Fellowship - 2011-2014 
  • Medical School: University of Pennsylvania, School of Medicine (Graduated 2006) 
  • Residency:  University of Pennsylvania (Graduated 2011) 

Current Position:
Chief Medical Officer
Embold Health
1801 West End Avenue
Nashville, TN 37203
Kirk (Pat) Keegan, MD, MPH

  • Vanderbilt Urologic Oncology Fellowship - 2010-2012 
  • Medical School: Georgetown University, School of Medicine (Graduated 2004) 
  • Residency:  University of CA, Davis (Graduated 2010)

Current Position:
Assistant Professor of Urology
Vanderbilt University Medical Center
A-1302 Medical Center North
Nashville, TN 37232
Todd Morgan, MD

  • Vanderbilt Urologic Oncology Fellowship - 2009-2011 
  • Medical School: Harvard Medical School (Graduated 2003) 
  • Residency:  University of Washington (Graduated 2009) 

Current Position:
Associate Professor of Urologic Surgery
University of Michigan
Department of Urology
Taubman Center Floor 2 Reception C
1500 E Medical Center Dr SPC 5330
Ann Arbor, MI 48109
Alison M. Christie, MD

  • Vanderbilt Urologic Oncology Fellowship - 2009-2010 
  • Medical School: Jefferson Medical College 
  • Residency: University of Michigan Health System 

Current Position:
Section Chief, Urology
James H. Quillen VA Medical Center
PO Box 4000
Mountain Home, TN 37684
Carl J. Bischoff, MD

  • Vanderbilt Urologic Oncology Fellowship - 2008-2009 
  • Medical School: Louisiana State University Medical School (Graduated 2004) 
  • Residency: University of Florida at Gainesville (Graduated 2009) 

Current Position:
Urology Austin
1401 Medical Parkway, Building B, 307
Cedar Park, TX 78613
Daniel A. Barocas, MD, MPH

  • Vanderbilt Urologic Oncology Fellowship - 2007-2009 
  • Medical School: Johns Hopkins University School of Medicine (Graduated 2001) 
  • Residency: New York Presbyterian Hospital-Weill Cornell Medical Center (Graduated 2007) 

Current position:
Associate Professor of Urologic Surgery
Vanderbilt University Medical Center
A-1302 Medical Center North
Nashville, TN 37232